Filing Details

Accession Number:
0000947871-10-000022
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-05 12:00:00
Reporting Period:
2009-12-24
Filing Date:
2010-01-05
Accepted Time:
2010-01-05 10:26:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1053369 Elite Pharmaceuticals Inc ELTP Pharmaceutical Preparations (2834) 223542636
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1211019 Trellus Partners Ii Lp C/O Trellus Management Company, Llc
350 Madison Avenue
New York NY 10017
No No Yes No
1307877 Trellus Management Company, Llc 350 Madison Avenue - 9Th Fl
New York NY 10017
No No Yes No
1458673 Ltd Fund Offshore Trellus 350 Madison Avenue, 9Th Floor
New York NY 10017
No No Yes No
1459107 Adam Usdan C/O Trellus Management Company, Llc
350 Madison Avenue, 9Th Floor
New York NY 10017
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2009-12-24 80,000 $0.11 24,321,777 No 4 S Indirect See footnote
Common Stock Disposition 2009-12-29 39,250 $0.11 24,282,527 No 4 S Indirect See footnote
Common Stock Disposition 2009-12-30 80,750 $0.11 24,201,777 No 4 S Indirect See footnote
Common Stock Disposition 2009-12-31 212,500 $0.11 23,989,277 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. On December 24, 2009, Trellus Partners, L.P., a Delaware limited partnership ("TPLP") sold 53,200 shares of Common Stock and Trellus Offshore Fund Limited, a Cayman Islands limited liability company ("TOF") sold 26,800 shares of Common Stock.
  2. On December 24, 2009, following the reported transaction, TPLP owned 13,052,079 shares of Common Stock and held warrants to acquire 3,291,426 shares of common Stock and TOF owned 6,399,532 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock. Trellys Manatement Company, LLC ("Trellus") and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF and in addition held indirect beneficial ownership of an additional 167,103 shares of Common Stock and additional warrants to acquire 33,879 shares of Common Stock.
  3. Trellus is the investment adviser to TPLP and TOF. Adam Usdan is the controlling principal and chief investment officer of Trellus. By reason of their investment discretion, Trellus and Mr. Usdan are reported herein as indirect beneficial owners of the securities held, acquired, and sold short against the box by TPLP and TOF (as described in footnotes (5) and (6)).
  4. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
  5. On December 29, 2009, TPLP sold 26,158 shares of Common Stock and TOF sold 13,092 shares of Common Stock.
  6. On December 29, 2009, following the reported transaction, TPLP owned 13,025,921 shares of Common Stock and held warrants to acquire 3,291,426 shares of Common Stock and TOF owned 6,386,440 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock. Trellus and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF and in addition held indirect beneficial ownership of an additional 167,103 shares of Common Stock and additional warrants to acquire 33,879 shares of Common Stock.
  7. On December 30, 2009, TPLP sold 53,700 shares of Common Stock and TOF sold 27,050 shares of Common Stock.
  8. On December 30, 2009, following the reported transaction, TPLP owned 12,972,221 shares of Common Stock and held warrants to acquire 3,291,426 shares of Common Stock and TOF owned 6,359,390 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock. Trellus and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF and in addition held indirect beneficial ownership of an additional 167,103 shares of Common Stock and additional warrants to acquire 33,879 shares of Common Stock.
  9. On December 31, 2009, TPLP sold 141,300 shares of Common Stock and TOF sold 71,200 shares of Common Stock.
  10. On December 31, 2009, following the reported transaction, TPLP owned 12,830,921 shares of Common Stock and held warrants to acquire 3,291,426 shares of Common Stock and TOF owned 6,288,190 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock. Trellus and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF and in addition held indirect beneficial ownership of an additional 167,103 shares of Common Stock and additional warrants to acquire 33,879 shares of Common Stock.